关于成本效益分析的一则注释。
A note on cost-value analysis.
作者信息
Østerdal Lars Peter
机构信息
Department of Health Services Research, Institute of Public Health, University of Copenhagen, Denmark.
出版信息
Health Econ. 2003 Mar;12(3):247-50; discussion 251-3. doi: 10.1002/hec.719.
DOI:10.1002/hec.719
PMID:12605468
Abstract
We discuss 'cost-value analysis', a method for health care resource allocation suggested by Nord et al. (Nord E et al. Incorporating societal concerns for fairness in numerical valuations of health programmes. Health Econ 1999; 8: 25-39). Some difficulties and issues for future research are pointed out.
摘要
我们讨论了“成本-价值分析”，这是诺德等人提出的一种医疗保健资源分配方法（诺德 E 等人。将社会对公平的关注纳入健康计划的数值评估中。《健康经济学》1999 年；8：25 - 39）。同时指出了一些未来研究的困难和问题。
相似文献
1
A note on cost-value analysis.
Health Econ. 2003 Mar;12(3):247-50; discussion 251-3. doi: 10.1002/hec.719.
2
Toward a broader view of values in cost-effectiveness analysis of health.
Hastings Cent Rep. 1999 May-Jun;29(3):7-15.
3
Longevity bias in cost-effectiveness analysis.
Health Econ. 2008 Apr;17(4):523-34. doi: 10.1002/hec.1309.
4
Theory and methods of economic evaluation of health care.
Dev Health Econ Public Policy. 1996;4:1-245.
5
In defence of societal sovereignty: a comment on Nyman 'the inclusion of survivor consumption in CUA'.
Health Econ. 2006 Mar;15(3):311-3; discussion 319-22. doi: 10.1002/hec.1066.
6
[QALYs and fairness: health economic approaches to the fairness issue and their problems].
Gesundheitswesen. 2011 Oct;73(10):688-95. doi: 10.1055/s-0030-1270468. Epub 2011 Jan 21.
7
Rationing health care resources. Is the quality-adjusted life-year a helpful guide?
Can Fam Physician. 1994 Jan;40:123-4, 127-8.
8
Incorporating societal concerns for fairness in numerical valuations of health programmes.
Health Econ. 1999 Feb;8(1):25-39. doi: 10.1002/(sici)1099-1050(199902)8:1<25::aid-hec398>3.0.co;2-h.
9
Application of cost-effectiveness analysis to multiple products: a practical guide.
Am J Manag Care. 2002 Mar;8(3):211-8.
10
On the possibility of a bridge between CBA and CEA: comments on a paper by Dolan and Edlin.
J Health Econ. 2004 Sep;23(5):887-98. doi: 10.1016/j.jhealeco.2003.10.002.
引用本文的文献
1
A principled approach to non-discrimination in cost-effectiveness.
Eur J Health Econ. 2024 Nov;25(8):1393-1416. doi: 10.1007/s10198-023-01659-7. Epub 2024 Feb 27.
2
The value of thinly spread QALYs.
Pharmacoeconomics. 2006;24(9):845-53. doi: 10.2165/00019053-200624090-00003.
Zotero 插件